ID DLEC1_HUMAN Reviewed; 1755 AA. AC Q9Y238; Q9NSW0; Q9NTG5; DT 25-OCT-2005, integrated into UniProtKB/Swiss-Prot. DT 18-MAY-2010, sequence version 2. DT 27-MAR-2024, entry version 157. DE RecName: Full=Deleted in lung and esophageal cancer protein 1; DE AltName: Full=Deleted in lung cancer protein 1; DE Short=DLC-1; GN Name=DLEC1 {ECO:0000312|EMBL:BAA77624.1}; GN Synonyms=DLC1 {ECO:0000303|PubMed:10213508}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] {ECO:0000305, ECO:0000312|EMBL:BAA77624.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), ALTERNATIVE SPLICING, RP PUTATIVE FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND RP INVOLVEMENT IN LUNG CANCER; ESOPHAGEAL CANCER AND RENAL CANCER. RX PubMed=10213508; RA Daigo Y., Nishiwaki T., Kawasoe T., Tamari M., Tsuchiya E., Nakamura Y.; RT "Molecular cloning of a candidate tumor suppressor gene, DLC1, from RT chromosome 3p21.3."; RL Cancer Res. 59:1966-1972(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16641997; DOI=10.1038/nature04728; RA Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., RA Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., RA Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., RA Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., RA Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., RA Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., RA Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., RA Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., RA Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., RA Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., RA Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., RA Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., RA Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., RA Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., RA Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., RA Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., RA Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., RA Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.; RT "The DNA sequence, annotation and analysis of human chromosome 3."; RL Nature 440:1194-1198(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 595-1755 (ISOFORM 2), AND RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1417-1755 (ISOFORM 3). RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [4] RP VARIANT [LARGE SCALE ANALYSIS] ARG-351. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., RA Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., RA Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., RA Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., RA Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal cancers."; RL Science 314:268-274(2006). RN [5] RP SUBCELLULAR LOCATION, AND INTERACTION WITH ALPHA-TUBULIN; BETA-TUBULIN; RP BBS2; BBS4; BBS5; MKKS; TCP1; CCT2; CCT3; CCT4; CCT5 AND CCT7. RX PubMed=33144677; DOI=10.1038/s41598-020-75957-y; RA Okitsu Y., Nagano M., Yamagata T., Ito C., Toshimori K., Dohra H., RA Fujii W., Yogo K.; RT "Dlec1 is required for spermatogenesis and male fertility in mice."; RL Sci. Rep. 10:18883-18883(2020). CC -!- FUNCTION: Essential for spermatogenesis and male fertility (By CC similarity). May play an important role in sperm head and tail CC formation (By similarity). May act as a tumor suppressor by inhibiting CC cell proliferation. {ECO:0000250|UniProtKB:Q8BLA1, CC ECO:0000269|PubMed:10213508}. CC -!- SUBUNIT: Interacts with alpha- and beta-tubulin (PubMed:33144677). CC Interacts with BBS2, BBS4, BBS5, MKKS, TCP1, CCT2, CCT3, CCT4, CCT5 and CC CCT7 (PubMed:33144677). {ECO:0000269|PubMed:33144677}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10213508, CC ECO:0000269|PubMed:33144677}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Comment=At least six differentially spliced products may exist. CC {ECO:0000303|PubMed:10213508}; CC Name=1 {ECO:0000303|PubMed:10213508}; CC IsoId=Q9Y238-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9Y238-2; Sequence=VSP_051847, VSP_051848, VSP_051849; CC Name=3; Synonyms=1S3 {ECO:0000303|PubMed:10213508}; CC IsoId=Q9Y238-3; Sequence=VSP_051850; CC -!- TISSUE SPECIFICITY: Expressed in all tissues examined. Expression is CC highest in prostate and testis. {ECO:0000269|PubMed:10213508}. CC -!- DISEASE: Note=DLEC1 silencing due to promoter methylation and aberrant CC transcription are implicated in the development of different cancers, CC including esophageal (ESCR), renal and lung cancers (LNCR). CC -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting CC tissues of the lung. The most common form of lung cancer is non-small CC cell lung cancer (NSCLC) that can be divided into 3 major histologic CC subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung CC cancer. NSCLC is often diagnosed at an advanced stage and has a poor CC prognosis. Note=The gene represented in this entry may be involved in CC disease pathogenesis. DLEC1 silencing due to promoter methylation and CC aberrant transcription are implicated in the development of lung CC cancer. CC -!- DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the CC esophagus. The most common types are esophageal squamous cell carcinoma CC and adenocarcinoma. Cancer of the esophagus remains a devastating CC disease because it is usually not detected until it has progressed to CC an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The CC gene represented in this entry may be involved in disease pathogenesis. CC DLEC1 silencing due to promoter methylation and aberrant transcription CC may be implicated in the development of esophageal cancer. CC -!- MISCELLANEOUS: [Isoform 2]: Levels of this splice isoform may be CC increased in cancer cell lines and primary cancers. CC {ECO:0000303|PubMed:10213508, ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform 3]: Levels of this splice isoform are increased CC in cancer cell lines and primary cancers. CC {ECO:0000269|PubMed:10213508}. CC -!- SEQUENCE CAUTION: CC Sequence=CAB70676.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305}; CC Sequence=CAB70884.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB026898; BAA77624.1; -; Genomic_DNA. DR EMBL; AB020522; BAA77247.1; -; mRNA. DR EMBL; AC144536; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP006309; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL137706; CAB70884.2; ALT_INIT; Transcribed_RNA. DR EMBL; AL137282; CAB70676.1; ALT_SEQ; mRNA. DR CCDS; CCDS2672.2; -. [Q9Y238-1] DR PIR; T46351; T46351. DR PIR; T46406; T46406. DR RefSeq; NP_001308082.1; NM_001321153.1. DR RefSeq; NP_031361.2; NM_007335.3. [Q9Y238-1] DR RefSeq; NP_031363.2; NM_007337.3. [Q9Y238-3] DR AlphaFoldDB; Q9Y238; -. DR SMR; Q9Y238; -. DR BioGRID; 115266; 12. DR IntAct; Q9Y238; 2. DR STRING; 9606.ENSP00000308597; -. DR iPTMnet; Q9Y238; -. DR PhosphoSitePlus; Q9Y238; -. DR BioMuta; DLEC1; -. DR DMDM; 296434480; -. DR EPD; Q9Y238; -. DR MassIVE; Q9Y238; -. DR PaxDb; 9606-ENSP00000308597; -. DR PeptideAtlas; Q9Y238; -. DR ProteomicsDB; 85633; -. [Q9Y238-1] DR ProteomicsDB; 85634; -. [Q9Y238-2] DR ProteomicsDB; 85635; -. [Q9Y238-3] DR Antibodypedia; 6364; 207 antibodies from 25 providers. DR DNASU; 9940; -. DR Ensembl; ENST00000308059.11; ENSP00000308597.6; ENSG00000008226.20. [Q9Y238-1] DR Ensembl; ENST00000346219.7; ENSP00000315914.5; ENSG00000008226.20. [Q9Y238-3] DR GeneID; 9940; -. DR KEGG; hsa:9940; -. DR MANE-Select; ENST00000308059.11; ENSP00000308597.6; NM_007335.4; NP_031361.2. DR UCSC; uc003cho.2; human. [Q9Y238-1] DR AGR; HGNC:2899; -. DR CTD; 9940; -. DR DisGeNET; 9940; -. DR GeneCards; DLEC1; -. DR HGNC; HGNC:2899; DLEC1. DR HPA; ENSG00000008226; Tissue enhanced (choroid plexus, fallopian tube, testis). DR MalaCards; DLEC1; -. DR MIM; 133239; phenotype. DR MIM; 211980; phenotype. DR MIM; 604050; gene. DR neXtProt; NX_Q9Y238; -. DR OpenTargets; ENSG00000008226; -. DR Orphanet; 99977; Squamous cell carcinoma of the esophagus. DR PharmGKB; PA27353; -. DR VEuPathDB; HostDB:ENSG00000008226; -. DR eggNOG; ENOG502QQQ5; Eukaryota. DR GeneTree; ENSGT00390000006098; -. DR HOGENOM; CLU_003422_0_0_1; -. DR InParanoid; Q9Y238; -. DR OMA; YWDSLIC; -. DR OrthoDB; 315510at2759; -. DR PhylomeDB; Q9Y238; -. DR TreeFam; TF340616; -. DR PathwayCommons; Q9Y238; -. DR SignaLink; Q9Y238; -. DR BioGRID-ORCS; 9940; 11 hits in 1140 CRISPR screens. DR ChiTaRS; DLEC1; human. DR GenomeRNAi; 9940; -. DR Pharos; Q9Y238; Tbio. DR PRO; PR:Q9Y238; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q9Y238; Protein. DR Bgee; ENSG00000008226; Expressed in right uterine tube and 144 other cell types or tissues. DR ExpressionAtlas; Q9Y238; baseline and differential. DR GO; GO:0005929; C:cilium; IBA:GO_Central. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB. DR GO; GO:0048487; F:beta-tubulin binding; IDA:UniProtKB. DR GO; GO:0015631; F:tubulin binding; IBA:GO_Central. DR GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW. DR GO; GO:0002357; P:defense response to tumor cell; IMP:ARUK-UCL. DR GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc. DR GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB. DR Gene3D; 2.60.40.10; Immunoglobulins; 7. DR InterPro; IPR033304; DLEC1. DR InterPro; IPR013783; Ig-like_fold. DR PANTHER; PTHR46348; DELETED IN LUNG AND ESOPHAGEAL CANCER PROTEIN 1; 1. DR PANTHER; PTHR46348:SF1; DELETED IN LUNG AND ESOPHAGEAL CANCER PROTEIN 1; 1. DR Genevisible; Q9Y238; HS. PE 1: Evidence at protein level; KW Alternative splicing; Cytoplasm; Differentiation; Reference proteome; KW Spermatogenesis; Tumor suppressor. FT CHAIN 1..1755 FT /note="Deleted in lung and esophageal cancer protein 1" FT /id="PRO_0000079929" FT REGION 1..39 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1339..1360 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1529..1553 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 12..39 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 704 FT /note="E -> MARLRGGRIPAMPQPSPGQPAGTQWCFQGTVFALQ (in isoform FT 2)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_051847" FT VAR_SEQ 856..885 FT /note="GPALIINVSALQFGLLRLGQKATNSIQIRN -> PFSLVCSAWGRKPQTPSR FT SGTSASSQPHGA (in isoform 2)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_051848" FT VAR_SEQ 886..1755 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_051849" FT VAR_SEQ 1675..1755 FT /note="QQEPAKAAVAFRVSPNSGLLEARSANAPPTSIALQVFFTARSSELYESTMVV FT EGVLGEKSCTLRLRGQGSYDERYMLPHQP -> VVSCTSPRWWWKVCSVRSPAPCGSGA FT KAPMMRDTCCLTSPEAPPQPSAPGPSWRKNIAQGLGAALQHKDTDLGTWGPLGSSWNGR FT TPFHNGLSLGPHDMSSELT (in isoform 3)" FT /evidence="ECO:0000303|PubMed:17974005" FT /id="VSP_051850" FT VARIANT 79 FT /note="L -> R (in dbSNP:rs7625806)" FT /id="VAR_056860" FT VARIANT 192 FT /note="S -> F (in dbSNP:rs34012183)" FT /id="VAR_056861" FT VARIANT 351 FT /note="P -> R (in a breast cancer sample; somatic FT mutation)" FT /evidence="ECO:0000269|PubMed:16959974" FT /id="VAR_035908" FT VARIANT 1022 FT /note="K -> N (in dbSNP:rs36012922)" FT /id="VAR_056862" FT VARIANT 1150 FT /note="N -> D (in dbSNP:rs9840172)" FT /id="VAR_056863" FT VARIANT 1227 FT /note="L -> P (in dbSNP:rs9810085)" FT /id="VAR_056864" FT CONFLICT 704 FT /note="E -> M (in Ref. 2; CAB70884)" FT /evidence="ECO:0000305" FT CONFLICT 1442 FT /note="G -> R (in Ref. 1; BAA77624/BAA77247)" FT /evidence="ECO:0000305" SQ SEQUENCE 1755 AA; 195684 MW; CD4BDB5EEF24DF98 CRC64; METRSSKTRR SLASRTNECQ GTMWAPTSPP AGSSSPSQPT WKSSLYSSLA YSEAFHYSFA ARPRRLTQLA LAQRPEPQLL RLRPSSLRTQ DISHLLTGVF RNLYSAEVIG DEVSASLIKA RGSENERHEE FVDQLQQIRE LYKQRLDEFE MLERHITQAQ ARAIAENERV MSQAGVQDLE SLVRLPPVKS VSRWCIDSEL LRKHHLISPE DYYTDTVPFH SAPKGISLPG CSKLTFSCEK RSVQKKELNK KLEDSCRKKL AEFEDELDHT VDSLTWNLTP KAKERTREPL KKASQPRNKN WMNHLRVPQR ELDRLLLARM ESRNHFLKNP RFFPPNTRYG GKSLVFPPKK PAPIGEFQST EPEQSCADTP VFLAKPPIGF FTDYEIGPVY EMVIALQNTT TTSRYLRVLP PSTPYFALGL GMFPGKGGMV APGMTCQYIV QFFPDCLGDF DDFILVETQS AHTLLIPLQA RRPPPVLTLS PVLDCGYCLI GGVKMTRFIC KNVGFSVGRF CIMPKTSWPP LSFKAIATVG FVEQPPFGIL PSVFELAPGH AILVEVLFSP KSLGKAEQTF IIMCDNCQIK ELVTIGIGQL IALDLIYISG EKSQPDPGEL TDLTAQHFIR FEPENLRSTA RKQLIIRNAT HVELAFYWQI MKPNLQPLMP GETFSMDSIK CYPDKETAFS IMPRKGVLSP HTDHEFILSF SPHELRDFHS VLQMVLEEVP EPVSSEAESL GHSSYSVDDV IVLEIEVKGS VEPFQVLLEP YALIIPGENY IGINVKKAFK MWNNSKSPIR YLWGKISDCH IIEVEPGTGV IEPSEVGDFE LNFTGGVPGP TSQDLLCEIE DSPSPVVLHI EAVFKGPALI INVSALQFGL LRLGQKATNS IQIRNVSQLP ATWRMKESPV SLQERPEDVS PFDIEPSSGQ LHSLGECRVD ITLEALHCQH LETVLELEVE NGAWSYLPVY AEVQKPHVYL QSSQVEVRNL YLGVPTKTTI TLINGTLLPT QFHWGKLLGH QAEFCMVTVS PKHGLLGPSE ECQLKLELTA HTQEELTHLA LPCHVSGMKK PLVLGISGKP QGLQVAITIS KESSDCSTEQ WPGHPKELRL DFGSAVPLRT RVTRQLILTN RSPIRTRFSL KFEYFGSPQN SLSKKTSLPN MPPALLKTVR MQEHLAKREQ LDFMESMLSH GKGAAFFPHF SQGMLGPYQQ LCIDITGCAN MWGEYWDNLI CTVGDLLPEV IPVHMAAVGC PISSLRTTSY TIDQAQKEPA MRFGTQVSGG DTVTRTLRLN NSSPCDIRLD WETYVPEDKE DRLVELLVFY GPPFPLRDQA GNELVCPDTP EGGCLLWSPG PSSSSEFSHE TDSSVEGSSS ASNRVAQKLI SVILQAHEGV PSGHLYCISP KQVVVPAGGS STIYISFTPM VLSPEILHKV ECTGYALGFM SLDSKVEREI PGKRHRLQDF AVGPLKLDLH SYVRPAQLSV ELDYGGSMEF QCQASDLIPE QPCSGVLSEL VTTHHLKLTN TTEIPHYFRL MVSRPFSVSQ DGASQDHRAP GPGQKQECEE ETASADKQLV LQAQENMLVN VSFSLSLELL SYQKLPADQT LPGVDIQQSA SGEREMVFTQ NLLLEYTNQT TQVVPLRAVV AVPELQLSTS WVDFGTCFVS QQRVREVYLM NLSGCRSYWT MLMGQQEPAK AAVAFRVSPN SGLLEARSAN APPTSIALQV FFTARSSELY ESTMVVEGVL GEKSCTLRLR GQGSYDERYM LPHQP //